𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-acting injectable risperidone in treatment refractory patients: A 14-week open-label pilot study

✍ Scribed by Ric M. Procyshyn; Alasdair M. Barr; Sean Flynn; Chris Schenk; Soma Ganesan; William G. Honer


Book ID
119365605
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
113 KB
Volume
123
Category
Article
ISSN
0920-9964

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Safety and efficacy of long-acting injec
✍ Swapna Verma; Mythily Subramaniam; Edimansyah Abdin; Kang Sim; Alex Su; Nelson L πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 2 views

## Abstract The study aimed to evaluate the efficacy of long‐acting injectable risperidone (LAR) in Asian patients with schizophrenia spectrum disorders. Twenty‐five patients enrolled in this 6‐month open labelled study. They were switched from their current antipsychotic to LAR without a prior or